Global Opioid-Induced Constipation (OIC) Treatment Market Research Report 2016

Global Opioid-Induced Constipation (OIC) Treatment Market Research Report 2016

Category : Diagnostic and Biotech
Published On : January  2017
Pages : 108

request-discount


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
Notes:
Production, means the output of Opioid-Induced Constipation (OIC) Treatment
Revenue, means the sales value of Opioid-Induced Constipation (OIC) Treatment

This report studies Opioid-Induced Constipation (OIC) Treatment in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
 GlaxoSmithKline, Inc.,
 AstraZeneca plc, Inc., 
 Pfizer, Inc.,
 S.L.A. Pharma AG,
 AIKO Biotechnology, 
 Cubist Pharmaceuticals, 
 Salix Pharmaceuticals, Inc. 
 Takeda Pharmaceutical Company Limited
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Opioid-Induced Constipation (OIC) Treatment in these regions, from 2011 to 2021 (forecast), like
 North America
 Europe
 China
 Japan
 Southeast Asia
 India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
 Naloxegol
 Lubiprostone
 Methylnaltrexone Bromide
 Docusate Sodium
 Others (Osmotic laxatives, Emollient or lubricant cathartics, Bulk cathartics, Stimulant cathartics, Prostaglandins or prokinetic drugs)
Split by application, this report focuses on consumption, market share and growth rate of Opioid-Induced Constipation (OIC) Treatment in each application, can be divided into
 Oral
 Parenteral (Subcutaneous Injection)

Table of Contents

Global Opioid-Induced Constipation (OIC) Treatment Market Research Report 2016
1 Opioid-Induced Constipation (OIC) Treatment Market Overview
1.1 Product Overview and Scope of Opioid-Induced Constipation (OIC) Treatment
1.2 Opioid-Induced Constipation (OIC) Treatment Segment by Type
1.2.1 Global Production Market Share of Opioid-Induced Constipation (OIC) Treatment by Type in 2015
1.2.2 Naloxegol
1.2.3 Lubiprostone
1.2.4 Methylnaltrexone Bromide
1.2.5 Docusate Sodium
1.2.6 Others (Osmotic laxatives, Emollient or lubricant cathartics, Bulk cathartics, Stimulant cathartics, Prostaglandins or prokinetic drugs)
1.3 Opioid-Induced Constipation (OIC) Treatment Segment by Application
1.3.1 Opioid-Induced Constipation (OIC) Treatment Consumption Market Share by Application in 2015
1.3.2 Oral
1.3.3 Parenteral (Subcutaneous Injection)
1.4 Opioid-Induced Constipation (OIC) Treatment Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Opioid-Induced Constipation (OIC) Treatment (2011-2021)

2 Global Opioid-Induced Constipation (OIC) Treatment Market Competition by Manufacturers
2.1 Global Opioid-Induced Constipation (OIC) Treatment Production and Share by Manufacturers (2015 and 2016)
2.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Opioid-Induced Constipation (OIC) Treatment Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Opioid-Induced Constipation (OIC) Treatment Manufacturing Base Distribution, Sales Area and Product Type
2.5 Opioid-Induced Constipation (OIC) Treatment Market Competitive Situation and Trends
2.5.1 Opioid-Induced Constipation (OIC) Treatment Market Concentration Rate
2.5.2 Opioid-Induced Constipation (OIC) Treatment Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Opioid-Induced Constipation (OIC) Treatment Production, Revenue (Value) by Region (2011-2016)
3.1 Global Opioid-Induced Constipation (OIC) Treatment Production by Region (2011-2016)
3.2 Global Opioid-Induced Constipation (OIC) Treatment Production Market Share by Region (2011-2016)
3.3 Global Opioid-Induced Constipation (OIC) Treatment Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
3.10 India Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Opioid-Induced Constipation (OIC) Treatment Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption by Regions (2011-2016)
4.2 North America Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Opioid-Induced Constipation (OIC) Treatment Production, Revenue (Value), Price Trend by Type
5.1 Global Opioid-Induced Constipation (OIC) Treatment Production and Market Share by Type (2011-2016)
5.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Market Share by Type (2011-2016)
5.3 Global Opioid-Induced Constipation (OIC) Treatment Price by Type (2011-2016)
5.4 Global Opioid-Induced Constipation (OIC) Treatment Production Growth by Type (2011-2016)

6 Global Opioid-Induced Constipation (OIC) Treatment Market Analysis by Application
6.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption and Market Share by Application (2011-2016)
6.2 Global Opioid-Induced Constipation (OIC) Treatment Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Opioid-Induced Constipation (OIC) Treatment Manufacturers Profiles/Analysis
7.1 GlaxoSmithKline, Inc.,
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Opioid-Induced Constipation (OIC) Treatment Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 GlaxoSmithKline, Inc., Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 AstraZeneca plc, Inc.,
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Opioid-Induced Constipation (OIC) Treatment Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 AstraZeneca plc, Inc., Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Pfizer, Inc.,
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Opioid-Induced Constipation (OIC) Treatment Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Pfizer, Inc., Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 S.L.A. Pharma AG,
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Opioid-Induced Constipation (OIC) Treatment Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 S.L.A. Pharma AG, Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 AIKO Biotechnology,
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Opioid-Induced Constipation (OIC) Treatment Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 AIKO Biotechnology, Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Cubist Pharmaceuticals,
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Opioid-Induced Constipation (OIC) Treatment Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Cubist Pharmaceuticals, Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Salix Pharmaceuticals, Inc.
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Opioid-Induced Constipation (OIC) Treatment Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Salix Pharmaceuticals, Inc. Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Takeda Pharmaceutical Company Limited
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Opioid-Induced Constipation (OIC) Treatment Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Takeda Pharmaceutical Company Limited Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview

8 Opioid-Induced Constipation (OIC) Treatment Manufacturing Cost Analysis
8.1 Opioid-Induced Constipation (OIC) Treatment Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Opioid-Induced Constipation (OIC) Treatment

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Opioid-Induced Constipation (OIC) Treatment Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Opioid-Induced Constipation (OIC) Treatment Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Opioid-Induced Constipation (OIC) Treatment Market Forecast (2016-2021)
12.1 Global Opioid-Induced Constipation (OIC) Treatment Production, Revenue Forecast (2016-2021)
12.2 Global Opioid-Induced Constipation (OIC) Treatment Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Opioid-Induced Constipation (OIC) Treatment Production Forecast by Type (2016-2021)
12.4 Global Opioid-Induced Constipation (OIC) Treatment Consumption Forecast by Application (2016-2021)
12.5 Opioid-Induced Constipation (OIC) Treatment Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix
Disclosure Section
Research Methodology
Data Source
Disclaimer



List of Tables and Figures

Figure Picture of Opioid-Induced Constipation (OIC) Treatment
Figure Global Production Market Share of Opioid-Induced Constipation (OIC) Treatment by Type in 2015
Figure Product Picture of Naloxegol
Table Major Manufacturers of Naloxegol
Figure Product Picture of Lubiprostone
Table Major Manufacturers of Lubiprostone
Figure Product Picture of Methylnaltrexone Bromide
Table Major Manufacturers of Methylnaltrexone Bromide
Figure Product Picture of Docusate Sodium
Table Major Manufacturers of Docusate Sodium
Figure Product Picture of Others (Osmotic laxatives, Emollient or lubricant cathartics, Bulk cathartics, Stimulant cathartics, Prostaglandins or prokinetic drugs)
Table Major Manufacturers of Others (Osmotic laxatives, Emollient or lubricant cathartics, Bulk cathartics, Stimulant cathartics, Prostaglandins or prokinetic drugs)
Table Opioid-Induced Constipation (OIC) Treatment Consumption Market Share by Application in 2015
Figure Oral Examples
Figure Parenteral (Subcutaneous Injection) Examples
Figure North America Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Opioid-Induced Constipation (OIC) Treatment Capacity of Key Manufacturers (2015 and 2016)
Table Global Opioid-Induced Constipation (OIC) Treatment Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Opioid-Induced Constipation (OIC) Treatment Capacity of Key Manufacturers in 2015
Figure Global Opioid-Induced Constipation (OIC) Treatment Capacity of Key Manufacturers in 2016
Table Global Opioid-Induced Constipation (OIC) Treatment Production of Key Manufacturers (2015 and 2016)
Table Global Opioid-Induced Constipation (OIC) Treatment Production Share by Manufacturers (2015 and 2016)
Figure 2015 Opioid-Induced Constipation (OIC) Treatment Production Share by Manufacturers
Figure 2016 Opioid-Induced Constipation (OIC) Treatment Production Share by Manufacturers
Table Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Opioid-Induced Constipation (OIC) Treatment Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Opioid-Induced Constipation (OIC) Treatment Revenue Share by Manufacturers
Table 2016 Global Opioid-Induced Constipation (OIC) Treatment Revenue Share by Manufacturers
Table Global Market Opioid-Induced Constipation (OIC) Treatment Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Opioid-Induced Constipation (OIC) Treatment Average Price of Key Manufacturers in 2015
Table Manufacturers Opioid-Induced Constipation (OIC) Treatment Manufacturing Base Distribution and Sales Area
Table Manufacturers Opioid-Induced Constipation (OIC) Treatment Product Type
Figure Opioid-Induced Constipation (OIC) Treatment Market Share of Top 3 Manufacturers
Figure Opioid-Induced Constipation (OIC) Treatment Market Share of Top 5 Manufacturers
Table Global Opioid-Induced Constipation (OIC) Treatment Capacity by Regions (2011-2016)
Figure Global Opioid-Induced Constipation (OIC) Treatment Capacity Market Share by Regions (2011-2016)
Figure Global Opioid-Induced Constipation (OIC) Treatment Capacity Market Share by Regions (2011-2016)
Figure 2015 Global Opioid-Induced Constipation (OIC) Treatment Capacity Market Share by Regions
Table Global Opioid-Induced Constipation (OIC) Treatment Production by Regions (2011-2016)
Figure Global Opioid-Induced Constipation (OIC) Treatment Production and Market Share by Regions (2011-2016)
Figure Global Opioid-Induced Constipation (OIC) Treatment Production Market Share by Regions (2011-2016)
Figure 2015 Global Opioid-Induced Constipation (OIC) Treatment Production Market Share by Regions
Table Global Opioid-Induced Constipation (OIC) Treatment Revenue by Regions (2011-2016)
Table Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Regions (2011-2016)
Table 2015 Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Regions
Table Global Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
Table China Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
Table India Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption Market by Regions (2011-2016)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption Market Share by Regions (2011-2016)
Figure Global Opioid-Induced Constipation (OIC) Treatment Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Opioid-Induced Constipation (OIC) Treatment Consumption Market Share by Regions
Table North America Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Import & Export (2011-2016)
Table Europe Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Import & Export (2011-2016)
Table China Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Import & Export (2011-2016)
Table Japan Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Import & Export (2011-2016)
Table India Opioid-Induced Constipation (OIC) Treatment Production, Consumption, Import & Export (2011-2016)
Table Global Opioid-Induced Constipation (OIC) Treatment Production by Type (2011-2016)
Table Global Opioid-Induced Constipation (OIC) Treatment Production Share by Type (2011-2016)
Figure Production Market Share of Opioid-Induced Constipation (OIC) Treatment by Type (2011-2016)
Figure 2015 Production Market Share of Opioid-Induced Constipation (OIC) Treatment by Type
Table Global Opioid-Induced Constipation (OIC) Treatment Revenue by Type (2011-2016)
Table Global Opioid-Induced Constipation (OIC) Treatment Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Opioid-Induced Constipation (OIC) Treatment by Type (2011-2016)
Figure 2015 Revenue Market Share of Opioid-Induced Constipation (OIC) Treatment by Type
Table Global Opioid-Induced Constipation (OIC) Treatment Price by Type (2011-2016)
Figure Global Opioid-Induced Constipation (OIC) Treatment Production Growth by Type (2011-2016)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption by Application (2011-2016)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption Market Share by Application (2011-2016)
Figure Global Opioid-Induced Constipation (OIC) Treatment Consumption Market Share by Application in 2015
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption Growth Rate by Application (2011-2016)
Figure Global Opioid-Induced Constipation (OIC) Treatment Consumption Growth Rate by Application (2011-2016)
Table GlaxoSmithKline, Inc., Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline, Inc., Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline, Inc., Opioid-Induced Constipation (OIC) Treatment Market Share (2011-2016)
Table AstraZeneca plc, Inc., Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca plc, Inc., Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca plc, Inc., Opioid-Induced Constipation (OIC) Treatment Market Share (2011-2016)
Table Pfizer, Inc., Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer, Inc., Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc., Opioid-Induced Constipation (OIC) Treatment Market Share (2011-2016)
Table S.L.A. Pharma AG, Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table S.L.A. Pharma AG, Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
Figure S.L.A. Pharma AG, Opioid-Induced Constipation (OIC) Treatment Market Share (2011-2016)
Table AIKO Biotechnology, Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AIKO Biotechnology, Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
Figure AIKO Biotechnology, Opioid-Induced Constipation (OIC) Treatment Market Share (2011-2016)
Table Cubist Pharmaceuticals, Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cubist Pharmaceuticals, Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
Figure Cubist Pharmaceuticals, Opioid-Induced Constipation (OIC) Treatment Market Share (2011-2016)
Table Salix Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Salix Pharmaceuticals, Inc. Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
Figure Salix Pharmaceuticals, Inc. Opioid-Induced Constipation (OIC) Treatment Market Share (2011-2016)
Table Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceutical Company Limited Opioid-Induced Constipation (OIC) Treatment Production, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Pharmaceutical Company Limited Opioid-Induced Constipation (OIC) Treatment Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioid-Induced Constipation (OIC) Treatment
Figure Manufacturing Process Analysis of Opioid-Induced Constipation (OIC) Treatment
Figure Opioid-Induced Constipation (OIC) Treatment Industrial Chain Analysis
Table Raw Materials Sources of Opioid-Induced Constipation (OIC) Treatment Major Manufacturers in 2015
Table Major Buyers of Opioid-Induced Constipation (OIC) Treatment
Table Distributors/Traders List
Figure Global Opioid-Induced Constipation (OIC) Treatment Production and Growth Rate Forecast (2016-2021)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate Forecast (2016-2021)
Table Global Opioid-Induced Constipation (OIC) Treatment Production Forecast by Regions (2016-2021)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption Forecast by Regions (2016-2021)
Table Global Opioid-Induced Constipation (OIC) Treatment Production Forecast by Type (2016-2021)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption Forecast by Application (2016-2021)
Enquiry Before Buy